New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution.
Sharquie
Khalifa E
KE
Department of Dermatology and Venereology, College of Medicine, University of Baghdad, PO Box 61080, Postal Code 12114, Baghdad, Iraq. ksharquie@yahoo.uk.com
Al-Nuaimy
Adil A
AA
Al-Shimary
Fadhil A
FA
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D019287:Zinc Sulfate / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D019287:Zinc Sulfate